BMN 331

· BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN 331, covering 2024-05-16 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema [Phase 1, Phase 2]